Shannon Boye, Ph.D., is an associate professor in the department of ophthalmology at the University of Florida.
Shannon specializes in the design and development of gene-based therapies for ocular disease using recombinant adeno-associated viral (AAV) vectors. She’s published widely on gene therapy approaches for GUCY2D Leber Congenital Amaurosis (LCA1), the development of novel dosing methods and AAV capsids for efficient transduction of photoreceptors via intravitreally administered AAV vectors, and other technologies including dual vector platforms for delivery of large transgenes. She currently serves as Principal Investigator, Co-Principle Investigator or Co-Investigator on several federally and privately funded grants and is actively involved in the University of Florida’s teaching mission.
Shannon received her undergraduate degree in marine biology from Fairleigh Dickinson University and her doctorate in neuroscience from the University of Florida.